MPO and glioblastoma: In addition, recent spatial analyses of human glioblastoma tumor samples identified regions of activated (myeloperoxidase) macrophages that are associated with improved clinical outcomes, suggesting anti-tumorigenic roles for certain macrophage populations in patients (Karimi et al., 2023).